Articles from Instrument Business Outlook (August 31, 2008)

1-64 out of 64 article(s)

Title	Type	Words
Academia.	Brief article	136
Ahura Scientific.		18
AMETEK Advanced Measurement Technology's ORTEC business released.		14
Applied bio and Invitrogen set date for shareholder votes.	Brief article	235
Applied Biosystems.		16
Applied DNA Sciences and Smiths Detection signed a memorandum of understanding for Smiths to provide Applied DNA Sciences with exclusive use of the Bio-seeq PLUS platform for authentication, anticounterfeiting and antidiversion.		48
Big things come in small packages.		1174
BlueGnome.		19
Bruker enters microscopy market.	Company overview	243
Calypte Biomedical.		28
China's General Administration of Quality Supervision, Inspection and Quarantine named DuPont Qualicon.		26
Clinical.	Brief article	122
Embryome Sciences acquired an exclusive license to Advanced Cell Technology.		20
Embryome Sciences entered into a manufacturing and distribution agreement with Lifeline Cell Technology.		25
Fluidigm.		11
Fluidigm.		20
GE Healthcare.		10
Genetix names new CEO.		162
Hong Kong.	Brief article	171
Horiba Instruments acquires maker of surface area analyzers.		85
ICx Technologies.	Brief article	72
ICx Technologies.		19
Implant Sciences.		14
In April, QIAGEN NV entered into a license and supply agreement for BioHelix's Helicase Dependent Amplification technology.		22
In July, Cepheid revised its forecast for 2008 sales from $182-$189 million (see IBO 4/30/80) to $173-$177 million, with product sales expected to be $164-$167 million, due to lower-than-expected noncore clinical partner purchases from BD and Roche and lower Biothreat sales due to a reduction in tests used by the US Postal Service.		76
In July, Lonza became the exclusive distributor of Bar Harbor BioTechnology.		17
In July, Sigma-Aldrich partnered with India's Metahelix Life Sciences.		23
In June, Australia's publicly listed QRSciences acquired US-listed Diversified Opportunities.		14
In June, the US Court of Appeals for the Second Circuit vacated in part a 2006 jury verdict against L-3 Communications for breach of fiduciary duty and for fraud that awarded OSI $126 million (see IBO 5/31/06).		60
In May, BIOTECON Diagnostics licensed rights to Applied Biosystems.		17
In May, the US Transportation Security Administration certified Reveal Imaging Technologies' dual-row CT-80DR explosives detection system (EDS) for screening checked baggage.		26
India.		118
Invitrogen and the Genome Quebec and Montreal Health Institute announced a collaboration.		24
Invitrogen.		20
Invitrogen.		7
Israel.	Brief article	115
Korea.	Brief article	114
LifeSpan BioScience.		25
Lonza Bioscience.		40
Lonza.		15
Market profile: asymetric-flow field flow fractionation.		463
Merck KGaA began selling BIOTECON Diagnostics.		12
Metals.		94
Millipore.		15
Norgen Biotek.		16
Profit taking makes for mixed IBO stock indexes.		3486
Promega.		17
Q2 results shine in gloomy economy.		2776
R&D.	Brief article	152
Roche Applied Science.		15
Roche Diagnostics granted a license to BIOTECON Diagnostics GmbH for the development.		31
Roche Diagnostics licensed its melting curve technology to Agilent.		11
Smith Detection.		19
Smiths Detection and Torion Technologies announced a strategic partnership in August.		26
Smiths Detection.		9
Smiths Detection.		50
SuperArray Bioscience changed its name to SABiosciences.		9
Techcomp acquires majority of Chinese supplier.	Brief article	87
The Beijing Genome Institute and PentaBase ApS are developing real-time.		18
The bottom line.	Statistical table	548
The US Department of Homeland Security awarded a $9.1 million Phase IIIX contract.		24
Thermo Fisher Scientific.		13
Thermo Fisher Scientific.		15
Thermo Fisher Scientific.		19